Abstract
We and others have identified CD73 as a new cancer target. I hereafter discuss that targeted blockade of CD73 has the effect of a "double-edge sword," able on the one hand to rescue endogenous adaptive anti-tumor immune responses, and on the other hand, inhibit the metastatic potential of tumor cells. © 2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Stagg, J. (2012). The double-edge sword effect of anti-CD73 cancer therapy. OncoImmunology. https://doi.org/10.4161/onci.1.2.18101
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free